low financeVERIFIED
J&J looks to buy Ollin Biosciences for up to $3.4 billion, FT says
Verified: 2 outlets in 2 countries have reported this story since Nov 16.
🕐 37m ago·2 outlets
How sure are we
✓ Verified · 2 outlets
Two or more outlets reported this story and its reliability score reached 65%, so WorldPulse marks it verified. That means more than one outlet says so, not that it is proven true.
Who reported it
The story so far · 2 reports · · 2 countries✓ Verified Nov 16, 3:19 AM UTC
- Nov 16, 1:18 AM UTCFirst reportJohnson & Johnson looking to buy Ollin Biosciences for up to US$3.4bilnst.com.my ↗
- Nov 16, 3:19 AM UTC+2 h· you’re reading thisJ&J looks to buy Ollin Biosciences for up to $3.4 billion, FT saysinvesting.com ↗
- Verified: a second independent outlet reported itNov 16, 3:19 AM UTC · +2 h
Verification Log1
cross checkconfirmed90%
[Claude] Report 2 covers the same FT-reported J&J deal to buy Ollin Biosciences for up to $3.4 billion, with matching details.
37m agoPowered by WorldPulse Verification Engine
Reliability
Reliability ScoreVery high
85%Independent outlets2
Statusverified
AI checknone yet
Community flags0
Score bands
Very high80–100%
A highly rated outlet, or several independent outletsHigh60–79%
One well-rated outlet so farModerate40–59%
A lower-rated or state-run outlet, or one report of something seriousLow20–39%
A low-rated outlet on a serious or sensitive storyVery low0–19%
Treat it as unconfirmedWhat moves the score
◎
Outlet ratingThe outlet’s rating in WorldPulse’s list of sources starts the score
⇄
Independent outletsEach further outlet that reports the story closes 40% of the gap to 98%
±
Report detailsA few points either way: a summary and a place add a little; state-run outlets on conflict, politics or security, and single reports marked high or critical, lose some
Not in the score: AI checks and reader flags. Verified is separate: two or more independent outlets and a score of at least 65%.
Very high · How we score this
Risk Score
low risk